The struggling biotech firm, NovaGen Therapeutics, faced severe fiscal difficulties stemming from unsuccessful clinical trials and escalating debt. Their internal leadership lacked the skill to address the https://gretaemhr376441.mpeblog.com/74301600/biotech-cfo-services-a-case-study-in-financial-restructuring